In May 2026, researchers Drs. Vos and Becking reported to us, in a National Zoom, on their patient-driven project designed to identify treatment preferences of patients with WM.  In particular, for our Canadian audience, they presented a zoomed-in view of the Canadian demographics and our results.  The recording of the presentation is available here.

For those wanting a more in-depth read, the paper reporting on the WM-VOICE study has now been published online in Blood Neoplasia, and is available here: Treatment Preferences in Waldenström Macroglobulinemia: an International Discrete Choice Experiment in 1,455 Patients.